A 65-year-old male with diabetic retinopathy and CME presented to the BPEI retina clinic for continued management of his chronic ocular condition. His care was complicated by an inability to submit to ocular examinations in the clinic (due to psychological factors), thus requiring frequent examinations under anesthesia. His CME had previously responded well to intravitreal steroids given by an outside provider, without a known history of steroid-induced ocular hypertension. The patient received bilateral fluocinolone acetonide intravitreal implants; however, one implant was inadvertently injected into the subconjunctival space. The patient ultimately received another implant in that eye and his CME has been stable when assessed with retinal imaging and examinations under anesthesia. Different intravitreal steroid implants used in the treatment of CME will be discussed, including indications, contraindications, and risks.
Presentation Date: 08/09/2018
Issue Date: 08/01/2020